Commonly reported side effects of pegylated interferon and ribavirin | Download Table
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C - The Lancet
Consensus Interferon - an overview | ScienceDirect Topics
Mechanism of action of interferon and ribavirin in treatment of hepatitis C | Nature
Treatment of chronic hepatitis C in treatment-naïve patients
Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
Side Effects of Interferon and Ribavirin Combination Therapy in... | Download Table
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C - Karoll J. Cortez, Shyam Kottilil, 2015
Interferon: Long-Term Side Effects
PDF) ORIGINAL PAPER Combined interferon-alpha-2b and ribavirin therapy in patients with recurring chronic hepatitis C (genotype 1) following liver transplantation in Hungary | Imre Fehérvári - Academia.edu
Full article: Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
Interferon: Long-Term Side Effects
PDF) Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C
Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C | AAFP
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C | NEJM
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet
